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Prevention of Inappropriate Therapy
n Implantable Cardioverter-Defibrillators
esults of a Prospective, Randomized
tudy of Tachyarrhythmia Detection Algorithms
ominic A. M. J. Theuns, MSC,* A. Peter J. Klootwijk, MD, PHD,* Dick M. Goedhart, MSC,†
uc J. L. M. Jordaens, MD, PHD*
otterdam, the Netherlands
OBJECTIVES The purpose of this randomized study was to investigate the performance of single- and
dual-chamber tachyarrhythmia detection algorithms.
BACKGROUND A proposed benefit of dual-chamber implantable cardioverter-defibrillators (ICDs) is im-
proved specificity of tachyarrhythmia detection.
METHODS All ICD candidates received a dual-chamber ICD and were randomized to programmed
single- or dual-chamber detection. Of 60 patients (47 male, age 58 14 years, left ventricular
ejection fraction 30%), 29 had single-chamber and 31 had dual-chamber settings. The
detection results were corrected for multiple episodes within a patient with the generalized
estimating equations method.
RESULTS A total of 653 spontaneous arrhythmia episodes (39 patients) were classified by the
investigators; 391 episodes were ventricular tachyarrhythmia (32 patients). All episodes of
ventricular tachyarrhythmias were appropriately detected in both settings. In 25 patients, 262
episodes of atrial tachyarrhythmias were recorded. Detection was inappropriate for 109 atrial
tachyarrhythmia episodes (42%, 18 patients). Rejection of atrial tachyarrhythmias was not
significantly different between both groups (p  0.55). Episodes of atrial flutter/tachycardia
were significantly more misclassified (p  0.001). Overall, no significant difference in
tachyarrhythmia detection (atrial and ventricular) between both settings was demonstrated
(p  0.77).
CONCLUSIONS The applied detection criteria in dual-chamber devices do not offer benefits in the rejection
of atrial tachyarrhythmias. Discrimination of atrial tachyarrhythmias with a stable atrioven-
tricular relationship remains a challenge. (J Am Coll Cardiol 2004;44:2362–7) © 2004 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.039the American College of Cardiology Foundation
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tespite the proven benefit from advancing implantable
ardioverter-defibrillator (ICD) technology, a substantial
roportion of ICD recipients experience inappropriate ICD
herapy due to atrial tachyarrhythmias (1–5). In patients
ith a single-chamber device, inappropriate classification of
trial tachyarrhythmias occurs in approximately 20% to 30%
f patients (1,6,7). The development of dual-chamber
evices provides the opportunity to improve the accuracy of
achyarrhythmia detection by the addition of atrial infor-
ation (8,9). The superiority of detection algorithms in
ual-chamber ICDs has not been proven so far. Prospective,
andomized studies evaluating the efficacy of dual-chamber
etection algorithms are lacking. The advantages of dual-
hamber ICDs for accurate discrimination are small or even
onexistent (10,11). Even more, dual-chamber pacing offers
o clinical advantage over ventricular backup pacing in ICD
atients with no indication for cardiac pacing (12).
From the *Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam,
he Netherlands; and the †Department of Statistics, Cardialysis, Rotterdam, the
etherlands. Supported by research grants from Biotronik (the Netherlands) and
uidant (the Netherlands).N
Manuscript received June 9, 2004; revised manuscript received August 16, 2004,
ccepted September 4, 2004.We designed a prospective, randomized study to compare
he performance of tachyarrhythmia detection algorithms in
ingle-chamber and dual-chamber ICDs.
ETHODS
tudy design. The Prevention of Inappropriate (PINAPP)
herapy study was a single-center, prospective, randomized
tudy of patients comparing single- and dual-chamber
iscrimination criteria. All patients had a standard indica-
ion for ICD implantation for the treatment of ventricular
achyarrhythmias but without an indication for antibrady-
ardia pacing. Patients with permanent atrial fibrillation
AF) or an indication for resynchronization therapy were
xcluded from the trial. The clinical characteristics of the
atients are summarized in Table 1.
The local ethical committee approved the study. Written
nformed consent was obtained from all patients before
tudy enrollment. All patients received a dual-chamber
evice. The patients were randomly assigned to have the
evice programmed to single-chamber supraventricular
etection algorithms (SC group) or to the enhanced
ual-chamber supraventricular detection algorithms (DC
roup). Random assignment was obtained by telephone
o an independent service (Cardialysis, Rotterdam, the
etherlands).
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December 21, 2004:2362–7 Inappropriate ICD Therapyevice description. The devices implanted in this study
ere, in equal numbers and randomized order, the Prizm
R (Guidant Corp., St. Paul, Minnesota) and the Tachos
R (Biotronik, Berlin, Germany). The pulse generator and
ndocardial leads were inserted through a single left pectoral
ncision. The endocardial lead used for the high right atrium
as a bipolar active-fixation lead with an interelectrode
pacing of 8.9 mm (Model 5076, Medtronic Inc., Minne-
polis, Minnesota). Far-field R-wave sensing in the atrial
lectrogram was excluded. If present, the atrial lead was
elocated until appropriate sensing could be achieved.
iscrimination of tachyarrhythmias. In both the SC
roup and DC group, the onset and stability criteria are
rovided to inhibit therapy in case of an atrial arrhythmia.
n addition, dual-chamber devices have “enhanced discrim-
nation” criteria to differentiate atrial from ventricular ar-
hythmias. In the Prizm DR, enhanced criteria are: 1) the
Abbreviations and Acronyms
AF  atrial fibrillation
AFL  atrial flutter
AT  atrial tachycardia
DC group  dual-chamber supraventricular detection
algorithm group
GEE  generalized estimating equation
ICD  implantable cardioverter-defibrillator
SC group  single-chamber supraventricular detection
algorithm group
ST  sinus tachycardia
able 1. Patient’s Clinical Characteristics (n  160)
SC Group
(n  29)
DC Group
(n  31) p Value
ender (M/F) 24/5 23/8 NS
ge (yrs) 57  17 61  10 NS
VEF (%) 29  11 31  10 NS
istory of atrial arrhythmias (n) 8 7 NS
nderlying cardiac disease (n)
CAD 21 26 NS
CMP (dilated) 6 3 NS
CMP (hyperthropic) 2 2 NS
resenting arrhythmia (n)
VF 7 9 NS
SMVT 17 15 NS
NSVT  inducible VT/VF 5 7 NS
harmacologic treatment (n)
Amiodarone 11 8 NS
Beta-blockers 17 17 NS
Digoxin 6 4 NS
No antiarrhythmic drug 7 7 NS
ACE inhibitor 21 26 NS
Diuretic 15 17 NS
Lipid-lowering drug 17 23 NS
CE  angiotensin-converting enzyme; CAD  coronary artery disease; CMP 
ardiomyopathy; DC group  dual-chamber supraventricular detection algorithm
roup; LVEF  left ventricular ejection fraction; NS  nonsignificant; NSVT 
on-sustained ventricular tachycardia; SC group  single-chamber supraventriculard
etection algorithm group; SMVT sustained monomorphic ventricular tachycardia;
F  ventricular fibrillation; VT  ventricular tachycardia.ventricular rate  atrial rate” criterion, and 2) the “AF rate
hreshold” criterion. When the ventricular rate  atrial rate
V A) is programmed, onset and stability are ignored, and
herapy will be delivered. The AF rate threshold (Afib
hreshold) criterion is programmed in conjunction with
tability. The aim of this feature is to suppress inappropriate
herapy for fast ventricular rates secondary to AF or atrial
utter (AFL). If the ventricular rhythm is classified unstable
nd the atrial rate is higher than the programmed Afib
hreshold, therapy is withheld (13).
The Tachos DR employs the SMART algorithm
Biotronik) as enhanced discrimination. This algorithm is
ased on continuous analysis of the average atrial and
entricular rate and their atrioventricular relationship,
hich results in three rate-branches (VV AA, VV AA,
nd VV  AA). The features of this algorithm have been
escribed in detail (14).
rogramming the devices. Throughout the study, the
evices were programmed similarly as often as possible to
acilitate comparison between both groups (Table 2). For all
atients, the tachyarrhythmia detection algorithms were
ctivated immediately after implantation. The SC group
as programmed to supraventricular tachycardia discrimi-
ation on the basis of ventricular rate combined with onset
15% to 16%) and stability (40 ms). For the DC group,
achyarrhythmia discrimination was programmed to onset
15% to 16%) and stability (40 ms), and all applicable
nhanced algorithms were activated. Safety timers were not
ctivated in both groups. The tachycardia detection zones
ere programmed to recognize fibrillation and either one or
wo tachycardia zones. The bradycardia support was pro-
rammed to VVI with a lower rate of 40/min for the SC
roup. The DC group was set to the DDI mode with a
ower rate of 40/min. The storage of intracardiac electro-
rams was programmed to collect both atrial and ventricular
ipolar electrograms and markers for all patients.
nd points. The primary end point in the study was the
eliverance of inappropriate therapy for atrial arrhythmias.
econdary end points were appropriate and inappropriate
rrhythmia classification. All spontaneous episodes detected
ither as ventricular tachyarrhythmia or as atrial tachyar-
hythmia with stored electrograms were retrieved from the
able 2. Programming of Detection Algorithms in the SC
roup and DC Group
SC Group DC Group
Biotronik Guidant Biotronik Guidant
nset (%) 15 16 15 16
tability (ms) 40 40 40 40
MART OFF NA ON NA
 A NA OFF NA ON
F threshold NA OFF NA 200/min
F  atrial fibrillation; NA  not applicable; V  A  ventricular rate  atrial rate;
ther abbreviations as in Table 1.evice’s memory. Two independent experienced physicians
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Inappropriate ICD Therapy December 21, 2004:2362–7nalyzed the stored episodes to assess the type of the clinical
rrhythmia and the appropriateness of device classification.
n case of doubt, a third physician was consulted to provide
he decision. The stored arrhythmias were classified as: 1)
entricular arrhythmia, or 2) atrial arrhythmia without a
o-existent ventricular arrhythmia. The atrial arrhythmias
ere further classified as AF, AFL, atrial tachycardia (AT),
nd sinus tachycardia (ST). Atrial fibrillation was assumed
o occur if the atrial electrogram showed a changing morphol-
gy. The diagnosis of AFL was based on regular AA intervals
nd no changes in morphology of the atrial electrogram. The
rerequisite of ST and AT was an atrial electrogram preceding
he ventricular electrogram. Sinus tachycardia was diagnosed if
he ventricular rhythm showed a gradual increase in heart rate
ith an unchanged morphology of the atrial and ventricular
lectrogram. In contrast, the diagnosis of AT was based on a
udden increase of the ventricular rate and a change in
orphology of the atrial electrogram.
tatistical analysis. Based on the assumption of a 30%
eduction in the incidence of inappropriate therapy with
ual-chamber devices, 27 patients were required in each, for
power of 80% and a probability value of 0.05.
Continuous variables were expressed as mean values 
D. Chi-square testing was used for analysis of categorical
ariables, and the Student t test was used for analysis of
ontinuous variables. A p value 0.05 was considered
tatistically significant.
The set of tachyarrhythmia episodes cannot be considered
s independent because patients contribute one or more
achyarrhythmia episodes to the dataset. To correct for
hese factors, statistical analysis was performed by using the
eneralized estimating equations (GEE) statistical method
ith an exchangeable correlation structure to correct the
arying number of episodes that were obtained from each
atient (15,16). Only episodes with a stored electrogram and
he physician’s classification were included in the analysis.
tatistical analysis was performed with SPSS for Windows
release 10.1, SPSS Inc., Chicago, Illinois) and SAS for
indows (release 8.2, SAS Institute, Cary, North Carolina).
Calculations were based on the possibility to accurately
etect ventricular arrhythmias (true positive [TP]), accu-
ately detect atrial arrhythmias (true negative [TN]), falsely
etect atrial arrhythmias as ventricular (false positive [FP]),
nd falsely detect ventricular arrhythmias as atrial (false
egative [FN]). The sensitivity of detection algorithms is
he probability that a ventricular arrhythmia is detected
hen present: [TP/(FN  TP)]. The specificity of detec-
ion algorithms is the ability to reject atrial tachyarrhyth-
ias. An absolute specificity cannot be calculated. The spec-
ficity is dependent on the prevalence of atrial
achyarrhythmias and the programmed detection interval
f the device. Therefore, we calculated the positive
redictive value of the detection algorithm as follows:
TP /(TP  FP)]. oESULTS
atient population. Sixty patients were included in the
tudy. A total of 29 patients were randomly assigned to the SC
roup and 31 to the DC group. Fifteen patients in the SC
roup were randomized to Biotronik and 14 patients to
uidant. In the DC group, 14 patients were randomized to
iotronik and 17 patients to Guidant. Baseline clinical char-
cteristics did not differ between the two groups (Table 1). At
he time of implantation, all patients had sinus rhythm. A
istory of atrial tachyarrhythmias was documented in 15
atients (25%), paroxysmal AF in 11 patients (18%), and
aroxysmal AFL in 2 patients (3%). Pharmacologic treatment
t discharge was not significantly different between the two
roups. Antiarrhythmic drug therapy was amiodarone in 19
atients (32%), beta-blockade in 34 patients (57%), and 10
atients (17%) received digoxin.
Five patients (8%) had two tachycardia zones activated.
n four of these patients, the programmed detection criteria
ere applicable to both tachycardia zones. The programmed
brillation and tachycardia zones were 290  14 ms and
87  34 ms, respectively. The programmed tachycardia
etection interval was not significantly different between the
wo groups (SC group, 379  31 ms vs. DC group, 389 
5 ms).
pontaneous tachyarrhythmias. The mean follow-up was
2 months, with a cumulative follow-up of 717 months.
uring this follow-up, 653 tachyarrhythmia episodes with
tored electrogram occurred in 39 patients (range 1 to 89
pisodes per patient). Figure 1 presents a tree diagram that
utlines the results of arrhythmia detection for each of the
53 stored tachyarrhythmia episodes. Based on the physi-
ian classification, there were a total of 391 episodes of true
entricular tachyarrhythmias in 32 patients (mean ventric-
lar rate 358  77 ms). In 25 patients, 262 episodes of true
trial tachyarrhythmias (mean ventricular rate 368 32 ms)
igure 1. Tree diagram showing the results for 653 stored spontaneous
achyarrhythmia episodes. DC group  dual-chamber supraventricular
etection algorithm group; EGM electrogram; pts patients; SC group
single-chamber supraventricular detection algorithm group; SVT 
upraventricular tachyarrhythmias; VT  ventricular tachycardia.ccurred. In Figure 2, the number of episodes for the two
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December 21, 2004:2362–7 Inappropriate ICD Therapytudy groups is presented. In the SC group, 166 episodes of
entricular tachyarrhythmias were recorded in 16 patients
range 1 to 57 episodes per patient); in the DC group, 225
pisodes in 16 patients (range 1 to 89 episodes per patient).
ll ventricular tachyarrhythmias were appropriately de-
ected in both groups. The sensitivity for ventricular tachy-
rrhythmias in both groups was 100%.
Of the 262 atrial tachyarrhythmia episodes in the ven-
ricular tachyarrhythmia detection window, 153 (58%) were
etected as atrial tachyarrhythmia and not as ventricular
achyarrhythmia (20 patients). Inappropriate detection was
bserved in 109 atrial tachyarrhythmia episodes (18 pa-
ients). The mean ventricular rate of misclassified atrial
achyarrhythmias was significantly shorter compared with
ejected atrial tachyarrhythmias (354  30 ms vs. 378  30
s; p  0.001). The number of misclassified episodes was
ot significantly different between the two groups (51 in the
C group vs. 58 in the DC group). Analysis performed with
he GEE method demonstrated no significant difference in
he rejection of spontaneous atrial tachyarrhythmias be-
ween single- and dual-chamber devices (p  0.56). The
etection of ventricular tachyarrhythmias and the rejection
f atrial tachyarrhythmias was not significantly different
etween the two groups (p  0.77). The specificity and
ositive predictive value of arrhythmia discrimination were
6% and 76% in the SC group, versus 60% and 79% in DC
roup, respectively.
During 60 atrial tachyarrhythmia episodes (13 patients),
nappropriate device therapy was delivered. The number of
nappropriately treated episodes was not significantly differ-
nt between the two groups (28 in the SC group vs. 32 in
he DC group).
ubanalysis of atrial tachyarrhytmias. The misclassified
trial tachyarrhythmias are presented in Table 3. Suba-
alysis of the type of atrial arrhythmia and the appropri-
teness of classification was performed with the GEE
ethod. Analysis demonstrated a significantly higher
isclassification in case of AFL/AT compared with ST
igure 2. Number of spontaneous episodes per patient for the two study
roups. The error bars extend down to the minimum value and up to the
aximum value. The box extends from the 25th percentile to the 75th
ercentile, with a black box at the median (50th percentile). Abbreviations
s in Figure 1.nd AF (p  0.001). The misclassified episodes of aT/AFL had a sudden onset 16% and a regular
entricular response (stability 40 ms). Episodes of ST
ere misclassified due to the presence of ventricular
remature beats that resulted in false sudden-onset cal-
ulations or false V  A detection in dual-chamber
evices.
ISCUSSION
he present prospective, randomized study evaluated the
erformance of tachyarrhythmia detection algorithms in
ingle-chamber and dual-chamber ICDs. Although identi-
al programmed stability and onset values were used, the
umber of inappropriate classifications with dual-chamber
etection was not significantly reduced compared with
ingle-chamber detection.
Inappropriate ICD therapy for atrial tachyarrhythmias is
he most common adverse event in ICD recipients with
ingle-chamber devices (17). With the development of
ual-chamber cardioverter-defibrillators, it was anticipated
hat these devices could improve arrhythmia detection by
roviding additional information about the underlying atrial
hythm. In previous studies, enhanced detection algorithms
n dual-chamber devices based on the atrioventricular rela-
ionship could accurately discriminate atrial from ventricular
achyarrhythmias (8,9). However, most of the studies were
estricted to one manufacturer and mainly focused on the
echnical performance of the implanted device (8,14,18–
0). Prospective, randomized studies to evaluate the efficacy
f enhanced detection algorithms to decrease the incidence
f inappropriate therapies are lacking in a well-defined
opulation.
ccuracy of tachyarrhythmia detection. The primary goal
f the ICD is to detect and subsequently terminate life-
hreatening ventricular tachyarrhythmias. When evaluating
achyarrhythmia detection criteria in our study, the sensi-
ivity for detection of ventricular tachyarrhythmias was
00% for both study groups. Single-chamber and dual-
hamber ICDs were equally safe and effective in treating
entricular tachyarrhythmias. This is in agreement with
ther device trials (8,10,11,14,18,19).
The secondary goal of the ICD is to deliver therapy only
hen required. Thus, accurate discrimination between atrial
nd ventricular tachyarrhythmias is an important clinical
ssue. The overall incidence of inaccurately detected tachy-
able 3. Inappropriate Classification of Spontaneous Atrial
achyarrhythmias for Both Groups
Misclassified Episodes
Arrhythmia (n)
SC Group
(%)
DC Group
(%) p Value
trial fibrillation 89 38 (2 patients) 26 (4 patients) NS
trial flutter 30 47 (1 patient) 50 (1 patient) NS
trial tachycardia 63 97 (6 patients) 96 (5 patients) NS
inus tachycardia 80 5 (1 patient) 18 (2 patients) NS
bbreviations as in Table 1.rrhythmias by the device was 16.7%. This finding is in
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Inappropriate ICD Therapy December 21, 2004:2362–7greement with studies reporting on inappropriate ICD
herapy (21,22). We found no significant difference in the
umber of misclassified episodes between both groups (51
pisodes, SC group vs. 58 episodes, DC group). The results
n our study demonstrated that enhanced detection criteria
n single-chamber and dual-chamber ICDs are equally effective
n the rejection of atrial tachyarrhythmias. This finding is
onfirmed by previous comparisons of enhanced detection
riteria between single- and dual-chamber ICDs (10,11).
hese investigators reported no reduction or even an excess of
nappropriate ICD therapies in dual-chamber devices. The
ailure of detection enhancements in dual-chamber devices to
ithhold therapy for atrial tachyarrhythmias was attributed by
he investigators to atrial sensing problems. Inappropriate
lassification of atrial tachyarrhythmias due to atrial sensing
roblems was also reported in other studies (19,23).
imitations of the applied enhanced detection criteria. The
trength and weakness of enhanced detection criteria are
ependent on the frequency and distribution of atrial
achyarrhythmias. The complete picture of the performance
f detection criteria is provided not only by statistical
easures. The picture is complemented with observations
uring misclassified atrial tachyarrhythmias. The observed
eaknesses of the applied detection criteria to discriminate
etween atrial and ventricular tachyarrhythmias were the
resence of: 1) atrial tachyarrhythmias with stable N:1
trioventricular conduction; and 2) ST with the presence of
entricular premature beats.
TRIAL TACHYARRHYTHMIAS WITH STABLE ATRIOVEN-
RICULAR CONDUCTION. In both settings, detection was
nappropriate in the majority of atrial tachyarrhythmias with
fixed N:1 atrioventricular conduction (AT and AFL). In
ingle-chamber setting, the sudden-onset (onset16%) and
he stable ventricular response (stability 40 ms) fulfilled
entricular tachyarrhythmia detection. Given the priority of
ingle-chamber detection criteria, the additional dual-
hamber detection enhancement “Afib threshold” cannot
ecrease the incidence of inappropriate detections for atrial
achyarrhythmias with stable N:1 atrioventricular conduc-
ion. A recent study confirmed the high incidence of
nappropriate classification of ATs with stable 1:1 atrioven-
ricular conduction (24).
Dual-chamber algorithms analyzing the atrioventricular
onduction have the possibility to detect stable atrial tachy-
rrhythmias with N:1 atrioventricular conduction. Despite
he use of the dual-chamber algorithm SMART, a variation
n the calculated mean atrial rates led to inappropriate
herapy in 2:1 conducted AFL. A progressively prolonging
trioventricular conduction interval can be misclassified as
entricular tachycardia with retrograde conduction. This
roblem has been reported as the most common failure of
he PR Logic algorithm (Medtronic Inc.) (19,25).
T. In case of ventricular premature beats during ST, the
ual-chamber detection enhancement “V A” can act as an
ccelerator of inappropriate detection. During a ventricular uremature beat, the normal atrial activation might be not
ensed due to the atrial blanking period after a sensed
entricular event, which fulfills the detection enhancement
V  A.” Another problem associated with premature
entricular beats is the inappropriate calculation of a sudden
nset. This problem has also been reported in previous
tudies (26,27).
omparison with other studies. A comparison of the
erformance of the applied detection criteria with other
tudies is difficult because the applied detection criteria, the
umber of episodes, the number of patients, and the
ethodology differ between the published studies. In an
pen-label nonrandomized study comparing single- and
ual-chamber devices, the incidence of inappropriate ther-
pies during AF was significantly higher in dual-chamber
evices compared with single-chamber devices (41% vs.
4%) (10). In a recent prospective, randomized study
etween single- and dual-chamber devices, no differences in
erformance of detection criteria were observed (11). How-
ver, the results must be interpreted with caution, because all
nappropriate therapies, including those in the ventricular
brillation zone and those not related to atrial tachyarrhyth-
ias, were considered in the study by Deisenhofer et al. (11).
Studies with dual-chamber ICDs have reported high
ensitivity and specificity values for the applied dual-
hamber algorithm. In a recent study with the PARAD
lgorithm (ELA Medical, Le Plessis Robinson, France), a
pecificity of 89.2% on a per episode basis and 91.6% on a
er patient basis were reported (20). Despite the high
verall specificity, the performance during AF was poor
47.2% of 53 episodes were inappropriately detected). Stud-
es evaluating the PR Logic algorithm reported lower
pecificity values of 66.6% or 72% on a per episode basis
19,25). For Guidant devices, the performance of “Afib
hreshold” and “V  A” in conjunction with a more
ggressively programmed onset (9%) and stability (24 ms)
as recently reported with a specificity of 89% (24).
imitations of the study. We used devices from only two
anufacturers to assess the accuracy of atrial tachyarrhyth-
ia detection in single- and dual-chamber ICDs. The
esults of our study must, therefore, be interpreted with
aution. The findings of the study do not reflect the status
f current detection algorithms in general. Current devices
an apply morphology discrimination in conjunction with
iming-based detection algorithms. The present study eval-
ated only timing-based detection algorithms. The pre-
efined programming of the onset (16%) and stability
riterion (40 ms) in the Guidant dual-chamber devices
otentially reduced the potential advantage of the enhance-
ent criteria (“V  A” and “Afib threshold”) (24). A more
ggressive onset and stability will first cause a loss in
ensitivity but an increase in specificity.
“V  A” will compensate the loss in sensitivity. As our
tudy demonstrated that not ST nor AF but AT and AFL
ith a fixed N:1 conduction were the problem, it is very
nlikely that lower stability values would have changed the
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December 21, 2004:2362–7 Inappropriate ICD Therapyesults. Another possible limitation is the number of pa-
ients. However, 653 episodes of tachyarrhythmias were
nalyzed. The programmed detection rate affects both the
istribution of the type of atrial tachyarrhythmias as well as
he relative number of atrial tachyarrhythmias presenting to
he detection algorithms. In our study, the programmed
etection rate was similar for both groups.
onclusions. In this study, using stored atrial electrograms
rom dual-chamber devices, the applied detection criteria in
ingle- and dual-chamber setting were equally effective for
etection of ventricular tachyarrhythmias and the rejection
f atrial tachyarrhythmias. This was true for this study
roup without a bradycardia indication. Both subgroups
ere comparable in terms of underlying heart disease,
ndication for implantation, antiarrhythmic drug therapy,
nd follow-up period. This has important repercussions on
ealth care in general, as in recent ICD trials, hospital
eadmissions due to new or worsened heart failure increased
5,12). This higher incidence was related to dual-chamber
radycardia pacing in patients without a bradycardia pacing
ndication. With the increasing indications for ICD im-
lantation, a matter of debate is the device selection. The
ules for device selection for patients with a primary pre-
ention indication can be different from those applied for
atients with a secondary prevention indication. Neverthe-
ess, to avoid inappropriate therapy, it is particularly impor-
ant to program carefully the enhanced detection criteria of
he device, irrespective of the indication. Further work
hould be done to improve arrhythmia discrimination, in
articular for atrial tachyarrhythmias with stable atrioven-
ricular conduction, which was most often misclassified.
eprint requests and correspondence: Dr. Luc Jordaens, Depart-
ent of Clinical Electrophysiology, Bd402, Erasmus MC, Dr.
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